Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 24 Nov 2021 for Adamas Pharmaceuticals Inc.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
John A. MacPhee: trading record in brief
This profile gathers the share dealings of John A. MacPhee in Adamas Pharmaceuticals Inc, where the filings describe the role as board member. Over a trading history stretching from 3 June 2020 to 24 November 2021, the count stands at 4 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 24 November 2021, the filings show a transaction in Adamas Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John A. MacPhee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
202,000 sharesCommon StockSEC:0001328143-21-000086:0
5,000 shares0Common StockSEC:0001328143-21-000058:0
2 of 2 declarations
